Nov 8 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results